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Abstract
Background  and  objectives:  Postdural  puncture  headache  (PDPH)  is  a  common  complication
following subarachnoid  blockade  and  its  incidence  varies  with  the  size  of  the  needle  used  and  the
needle design.  Suportive  therapy  is  the  usual  initial  approach.  Epidural  blood  patch  (EBP)  is  the
gold-standard  when  supportive  therapy  fails  but  has  signiﬁcant  risks  associated.  Sphenopalatine
ganglion block  (SPGB)  may  be  a  safer  alternative.
Case  report:  We  observed  a  41  year-old  female  patient  presenting  with  PDPH  after  a  sub-
arachnoid  blockade  a  week  before.  We  administrated  1  l  of  crystalloids,  Dexamethasone  4  mg,
parecoxib  40  mg,  acetaminophen  1  g  and  caffeine  500  mg  without  signiﬁcant  relief  after  2  h.
We performed  a  bilateral  SPGB  with  a  cotton-tipped  applicator  saturated  with  0.5%  Lev-
obupivacaine  under  standard  ASA  monitoring.  Symptoms  relief  was  reported  5  min  after  the
block. The  patient  was  monitored  for  an  hour  after  which  she  was  discharged  and  prescribed
acetaminophen  1  g  and  ibuprofen  400  mg  every  8  hours  for  the  following  2  days.  She  was  con-
tacted on  the  next  day  and  again  after  a  week  reporting  no  pain  in  both  situation.
Conclusions:  SPGB  may  attenuate  cerebral  vasodilation  induced  by  parasympathetic  stimulation
transmitted  through  neurons  that  have  synapses  in  the  sphenopalatine  ganglion.  This  would  be
in agreement  with  the  Monro-Kellie  concept  and  would  explain  why  caffeine  and  sumatriptan
can have  some  effect  in  the  treatment  of  PDPH.
Apparently,  SPGB  has  a  faster  onset  than  EBP  with  better  safety  proﬁle.  We  suggest  that
patients presenting  with  PDPH  should  be  considered  primarily  for  SPGB.  Patients  may  have  a
rescue EBP  if  needed.
© 2016  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
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Bloqueio  do  gânglio  esfenopalatino  para  cefaleia  pós-punc¸ão  dural  em  contexto
de  ambulatório
Resumo
Justiﬁcativa  e  objetivos:  Cefaleia  pós-punc¸ão  dural  (CPPD)  é  uma  complicac¸ão  comum  após
bloqueio subaracnoideo  e  sua  incidência  varia  de  acordo  com  o  tamanho  e  formato  da  agulha
utilizada.  Geralmente,  a  terapia  de  apoio  é  a  abordagem  inicial.  O  tampão  sanguíneo  peridural
(TSP) é  o  padrão  de  terapia  quando  a  terapia  de  apoio  falha,  mas  possui  riscos  signiﬁcativos
associados.  O  bloqueio  do  gânglio  esfenopalatino  (BGEP)  pode  ser  uma  alternativa  mais  segura.
Relato de  caso: Atendemos  uma  paciente  de  41  anos  de  idade,  apresentando-se  com  CPPD  após
um bloqueio  subaracnoideo  uma  semana  antes.  Administramos  cristaloides  (1  L),  dexametasona
(4 mg),  parecoxib  (40  mg),  acetaminofeno  (1  g)  e  cafeína  (500  mg),  sem  alívio  signiﬁcativo  após
2 horas.  Realizamos  um  bloqueio  bilateral  do  gânglio  esfenopalatino,  usando  um  aplicador  com
ponta de  algodão  saturada  com  levobupivacaína  a  0,5%  sob  monitorizac¸ão  padrão  ASA.  O  alívio
dos sintomas  foi  relatado  5  minutos  após  o  bloqueio.  A  paciente  foi  monitorada  por  uma  hora
e depois  recebeu  alta  com  prescric¸ão  de  acetaminofeno  (1  g)  e  ibuprofeno  (400  mg)  a  cada  8
horas para  os  dois  dias  seguintes.  A  paciente  foi  contatada  no  dia  seguinte  e  novamente  após
uma semana  e,  em  ambos  os  contatos,  relatou  não  sentir  dor.
Conclusões:  O  BGEP  pode  ter  atenuado  a  vasodilatac¸ão  cerebral  induzida  pelo  estímulo  paras-
simpático  transmitido  através  dos  neurônios  que  possuem  sinapses  no  gânglio  esfenopalatino.
Esse mecanismo  estaria  de  acordo  com  o  conceito  de  Monro-Kellie  e  explicaria  porque  a  cafeína
e o  sumatriptano  podem  ter  algum  efeito  no  tratamento  da  CPPD.
Aparentemente,  o  BGEP  tem  um  início  mais  rápido  que  o  do  TSP,  com  um  melhor  perﬁl  de
seguranc¸a. Sugerimos  que  os  pacientes  que  se  apresentam  com  CPPD  devam  ser  considerados
primeiro  para  BGEP.  Os  pacientes  podem  ser  submetidos  a  um  TSP  de  resgate,  caso  necessário.
© 2016  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um
artigo Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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cackground and objectives
ostdural  Puncture  Headache  is  a  common  complication  fol-
owing  subarachnoid  blockade.  Its  incidence  varies  greatly
ccording  to  the  used  needle  size  and  the  needle  design.  It
sually  presents  as  an  intense  frontal  and  occipital  headache
ut  other  areas  may  also  be  affected.1 The  pain  is  exac-
rbated  by  upright  position  and  is  relieved  by  lying  down,
hich  is  a  hallmark.2 Other  symptoms  have  also  been
eported  including  nausea  and  vomiting,  vertigo,  hearing
oss  and  even  visual  disturbances.  Despite  approximately
0%  of  PDPH  happening  in  the  ﬁrst  3  days  after  a  dural
uncture,  its  onset  may  be  delayed  for  almost  2  weeks.1
The  Quincke  needle  is  one  of  the  most  used  spinal  needles
orldwide  and  it  has  a  sharp  and  cutting  tip.  The  incidence
f  PDPH  using  Quincke  needles  may  vary  from  0.4%  up  to
6%  depending  of  its  size.  Pencil-point  needles  may  have
ower  incidence  of  PDHP.1 Rehydration,  non-steroidal  anti-
nﬂammatory  drugs,  acetaminophen,  low  dose  corticoids,
affeine  and  even  sumatriptan  are  all  part  of  supportive
herapy  which  may  obviate  the  need  for  more  aggressive
herapy  despite  incomplete  relief.3
The  EBP  is  currently  the  standard  of  care  after  failure  of
harmacological  therapies  but  it  is  not  devoided  of  signiﬁ-
ant  risks  (meningitis,  seizures,  motor  and  sensory  deﬁcits,Please  cite  this  article  in  press  as:  Cardoso  JM,  et  al.  Sphenop
ambulatory  setting.  Rev  Bras  Anestesiol.  2016.  http://dx.doi.o
tc.).4 Some  reports  of  transnasal  SPGB  have  been  emerging
or  the  treatment  of  PDPH.5
m
pase report
e  observed  a  41  year-old  female  patient  presenting  with
DPH  after  a subarachnoid  blockade  with  a  27  gauge  Quincke
eedle  for  a tension-free  vaginal  tape  obturator  a  week
efore.  The  intense  holocraneane  headache  had  started  at
he  night  of  surgery  and  it  was  aggravated  by  the  upright
osition  with  relief  by  lying  down.  The  patient  also  referred
ausea  and  vomiting  for  the  last  week.  No  neck  stiffness  was
ound.  We  proposed  a  brain  Computed  Tomography  (CT)  scan
hich  our  patient  refused  due  to  having  an  infant  at  home
rom  whom  she  did  not  feel  comfortable  being  separated.
We  administrated  1  l  of  crystalloids,  Dexamethasone
 mg,  parecoxib  40  mg,  acetaminophen  1  g and  caffeine
00  mg  without  signiﬁcant  relieve  after  2  h.  After  discussing
ith  the  patient  and  gathering  her  consent,  we  performed
 bilateral  SPGB  with  two  cotton-tipped  applicators  soaked
ith  0.5%  Levobupivacaine,  without  adjuncts  nor  vasocon-
trictors,  under  standard  ASA  monitoring.  The  cotton-tipped
pplicators  (one  for  each  nostril)  were  introduced  parallel
o  the  nose  ﬂoor  and  advanced  until  resistance  was  felt.
his  represents  contact  with  the  posterior  nasopharynx  wall.
ach  cotton-tipped  applicator  was  left  in  place  for  approxi-
ately  5  min.  Symptoms  relief  was  reported  5  min  after  the
otton-tipped  applicators  were  withdrawn.  The  patient  wasalatine  ganglion  block  for  postdural  puncture  headache  in
rg/10.1016/j.bjane.2016.09.003
onitored  for  an  hour  after  which  she  was  discharged  and
rescribed  acetaminophen  1  g  and  ibuprofen  400  mg  every
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8  h  for  the  following  2  days.  She  was  contacted  the  next  day
and  again  after  a  week  reporting  no  pain  in  both  situation.
Conclusions
Despite  PDPH  being  usually  a  clear  diagnosis  from  the  history
of  a  dural  puncture  and  the  clinical  ﬁndings,  other  diagnosis
must  be  considered  ranging  from  migraine  to  meningi-
tis,  intracranial  haemorrhage,  central  venous  thrombosis  or
cerebral  tumor.1 There  was  no  previous  history  of  migraine.
The  onset  and  lack  of  progression  of  neurological  symptoms
played  against  meningitis  and  intracranial  haemorrhage
would  likely  present  with  more  dramatic  features.  We  pro-
posed  a  brain  CT-scan  to  exclude  for  other  causes  but  our
patient  refused  it.
The  Monro-Kellie  concept  states  that  the  intracranial  vol-
ume  must  remain  ﬁxed.  Therefore,  if  there  is  a  cerebrospinal
ﬂuid  leakage  due  to  a  dural  puncture,  the  other  intracranial
constituents  (blood  and  brain  tissue)  would  have  to  increase
its  volume  so  that  the  intracranial  pressure  and  the  cere-
bral  perfusion  pressure  would  remain  in  the  normal  range.
Since  the  brain  tissue  is  a  solid  constituent  with  low  capac-
ity  to  expand  its  volume  in  an  acute  fashion,  the  remaining
possibility  is  for  the  intracranial  blood  volume  to  increase,
secondary  to  vasodilation.1
An  hypothesis  is  that  SPGB  may  attenuated  cere-
bral  vasodilation  induced  by  parasympathetic  stimulation
transmitted  through  neurons  that  have  synapses  in  thePlease  cite  this  article  in  press  as:  Cardoso  JM,  et  al.  Sphenopa
ambulatory  setting.  Rev  Bras  Anestesiol.  2016.  http://dx.doi.o
sphenopalatine  ganglion.  This  would  be  in  agreement  with
the  Monro-Kellie  concept  and  would  also  explain  why  caf-
feine  and  sumatriptan  can  have  some  effect  in  the  treatment
of  PDPH.
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Regarding  what  was  already  described  elsewhere,4,5 SPGB
as  apparently  a  faster  onset  than  EBP  with  better  safety
roﬁle.  Despite  obvious  contraindication  in  patients  with
asilar  skull  fractures,  we  can  argue  that  SPGB  can  walk
hrough  the  many  contraindications  for  an  EPD.  Also,  by
eing  a  non-invasive  technique,  little  worries  must  be  given
n  the  case  of  pyrexia,  hyperleukemia  or  know  infection
nywhere  else  than  the  nasopharynx.
We  suggest  that  patients  presenting  with  PDPH  should  be
onsidered  primarily  for  SPGB,  due  to  safety  of  the  proce-
ure.  Patients  may  have  a  rescue  EBP  if  needed.
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